gilberto lopes ✓

@GlopesMd · Miami, FL · joined 16 Nov 2013

Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief emeritus JCO GO, Board Member @UICC - chair #ATOMcoalition

37 564Followers

40 000Following

57 608Posts total

10.7KViews on collected posts

โพสต์ล่าสุด

gilberto lopes ✓@GlopesMd8 Sep

Visual summary of today’s phase 3 DeLLphi-305 update in ES-SCLC: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after induction durvalumab + platinum/etoposide. PFS and ORR also positive. Full data still needed. #SCLC #LCSM https://t.co/pyeQbPyoRc

1K views · 15 likes · 7 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

1/3 Big news in #SCLC today. Phase III DeLLphi-305: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after first-line platinum/etoposide + durvalumab in ES-SCLC. PFS and ORR also positive. Very encouraging—full data will matter. 1K views · 13 likes · 3 reposts · 2 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

@iaslc #WCLC26 @oncoalert @oncodaily @larvol @tribeMDUS @sylvestercancer @oncbrothers @chinmay @Jani_Chinmay @latinamd @colazagasti @openmedicineHQ @asco @myesmo @openmedkate @openmedben @chadinabhan 760 views · 6 likes · 2 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

Seoul, Rebuilt: What a City and the World Conference on Lung Cancer Can Teach Us About Progress https://t.co/b6TNHeXEOV @IASLC #WCLC26 @uicc 1.8K views · 19 likes · 6 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd20 Aug

@GlopesMd @WSJopinion Really nice piece my friend 👌🏻👍🏻 31 views · 1 likes · 0 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

@GlopesMd @WSJopinion well said 172 views · 1 likes · 1 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

“Americans grew richer in the goods that markets could freely supply, and poorer in the three purchases that define middle-class standing: a house, a degree and a doctor.” 2.5K views · 7 likes · 3 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd5 Aug

My piece @WSJopinion: Americans Got Wealthier but Don’t Feel Like It https://t.co/QiKHd2XY1Y https://t.co/HZNwsDLl8y

3.4K views · 8 likes · 3 reposts · 2 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

8 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม อยู่ที่ค่ามัธยฐานของช่วงผู้ติดตามพอดี.

ยอดดูมัธยฐาน1 025บัญชีนี้924ค่ามัธยฐานของ 10K–100K

การเข้าถึง, %2.73%บัญชีนี้3.62%ค่ามัธยฐานของ 10K–100K

การมีส่วนร่วม, %1.63%บัญชีนี้1.52%ค่ามัธยฐานของ 10K–100K

ตัวชี้วัด	บัญชีนี้	ค่ามัธยฐานของ 10K–100K	อัตราส่วน
ยอดดูมัธยฐานต่อโพสต์	1 025	924	1.11×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)	2.73%	3.62%	0.75×
อัตราการมีส่วนร่วม	1.63%	1.52%	1.07×

บัญชีอื่นในช่วงนี้ → เปรียบเทียบกับบัญชีอื่น → ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K5 Aug

2.5K6 Aug

172

3120 Aug

1.8K8 Sep

760

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%5 Aug

0.41%6 Aug

1.74%

3.23%20 Aug

1.51%8 Sep

1.05%

1.77%

2.22%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes63.1%70 in total

Reposts22.5%25 in total

Replies6.3%7 in total

Quotes1.8%2 in total

Bookmarks6.3%7 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

โพสต์ล่าสุด

เทียบกับบัญชีขนาดเดียวกัน

Growth & engagement

Views per post

Engagement rate per post

What the audience does

บัญชีที่คล้ายกัน